Loading...
Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment
This Review discusses the various types of non-coding oligonucleotides, which have garnered extensive interest as new alternatives for targeted cancer therapies over small molecule inhibitors and monoclonal antibodies. These oligonucleotides can target any hallmark of cancer, no longer limited to so...
Na minha lista:
Udgivet i: | Cancer Treat Rev |
---|---|
Main Authors: | , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4826844/ https://ncbi.nlm.nih.gov/pubmed/26930249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2016.02.005 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|